|
|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$94,395
|
N/A
|
National Institutes of Health
|
|
|
Failed Tubulin Inhibitor Reformulated as Localized Adjuvant Therapy for Head and
|
N43CA140043-000
|
$223,412
|
$111,706
|
"ROTHSTEIN, PH.D.", SAM
|
QRONO, INC.
|
|
|
The Role of CRL4-Cdt2 E3 Ubiquitin Ligase in Genomic Stability and Cancer
|
5R00CA140774-05
|
$241,530
|
$60,383
|
ABBAS, TAREK
|
UNIVERSITY OF VIRGINIA
|
|
|
Estrogen-ERbeta Axis In Disparity of Prostate Cancer
|
5U01CA149204-04
|
$271,258
|
$135,629
|
ABDEL-MAGEED, ASIM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
5K08CA178168-02
|
$140,674
|
$70,337
|
ABEL, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
4R00CA172697-02
|
$241,530
|
$241,530
|
ACHARYYA, SWARNALI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
5R01CA109339-10
|
$289,346
|
$72,337
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-04
|
$1,070,836
|
$53,542
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
|
Combinatorial Approach for Reducing Invasive Potential of Melanoma Cells
|
5R21CA173043-02
|
$154,540
|
$154,540
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Platelets promote growth of ovarian cancer
|
5R01CA177909-02
|
$322,040
|
$161,020
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS
|
5R01CA172623-02
|
$388,942
|
$388,942
|
AFT, REBECCA
|
WASHINGTON UNIVERSITY
|
|
|
Regulation of metastases by tumor suppressor INPP4B
|
1R15CA179287-01A1
|
$418,144
|
$418,144
|
AGOULNIK, IRINA
|
FLORIDA INTERNATIONAL UNIVERSITY
|
|
|
Small molecule antagonists of relaxin receptor
|
5U01CA177711-02
|
$288,313
|
$144,157
|
AGOULNIK, ALEXANDER
|
FLORIDA INTERNATIONAL UNIVERSITY
|
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-11
|
$341,794
|
$341,794
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
5R01CA180149-02
|
$557,736
|
$557,736
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-04
|
$283,563
|
$283,563
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
|
Elucidating the role and regulation of epithelial plasticity in metastasis
|
1F31CA177163-01A1
|
$42,676
|
$42,676
|
AIELLO, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
5R01CA152312-04
|
$344,687
|
$86,172
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
2P30CA138313-06
|
$1,495,000
|
$194,350
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
2U54CA143924-06
|
$1,374,976
|
$96,248
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Characterization of WWOX, the Cancer Gene Spanning FRA16D
|
5R01CA102444-10
|
$323,041
|
$323,041
|
ALDAZ, C.
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
p90RSK2-Stathmin Signaling in Metastatic Human Cancers
|
1F31CA183365-01
|
$42,676
|
$42,676
|
ALESI, GINA
|
EMORY UNIVERSITY
|
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
1R01CA177993-01A1
|
$601,659
|
$601,659
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
INFLAMMATORY CHEMOKINE CCL3 IN THE TUMOR MICROENVIRONMENT LEADS TO ENHANCED ANTIT
|
1F31CA192874-01
|
$33,648
|
$16,824
|
ALLEN, FREDERICK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
1R01CA183811-01A1
|
$427,850
|
$106,963
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
|
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
|
1R01CA190027-01
|
$383,875
|
$126,679
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$704,586
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Control of Apoptosis in Cancer by Survivin
|
2R01CA078810-17
|
$370,000
|
$370,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
$25,936
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-06
|
$1,197,703
|
$598,852
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
1R01CA178610-01A1
|
$320,971
|
$160,486
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-02
|
$332,350
|
$166,175
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Role of Splicing Factors in Breast Cancer
|
5K99CA178206-02
|
$106,008
|
$106,008
|
ANCZUKOW-CAMARDA, OLGA
|
COLD SPRING HARBOR LABORATORY
|
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
5K23CA157728-04
|
$174,017
|
$174,017
|
ANDERS, CAREY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
PI Signaling Role in Epithelial/Mesenchymal Transition
|
5R01CA104708-10
|
$279,739
|
$279,739
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4
|
5R21CA180211-02
|
$162,452
|
$162,452
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-05
|
$313,570
|
$78,393
|
ANDERSON, BRADLEY
|
UNIVERSITY OF KENTUCKY
|
|
|
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
|
5R01CA156661-05
|
$292,856
|
$87,857
|
ANDREANA, PETER
|
UNIVERSITY OF TOLEDO
|
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
1U01CA179671-01A1
|
$307,100
|
$307,100
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$618,864
|
$123,773
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$265,448
|
$90,252
|
Apolo, Andrea
|
CCR (NCI)
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$303,485
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$2,250
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$3,680
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
The Role of the Spectraplakin Short-Stop in Cell Migration
|
7K01CA163972-03
|
$87,341
|
$87,341
|
APPLEWHITE, DEREK
|
REED COLLEGE
|
|
|
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
|
5R01CA159959-04
|
$573,291
|
$573,291
|
ARBEIT, JEFFREY
|
WASHINGTON UNIVERSITY
|
|
|
SPORE in Breast Cancer
|
5P50CA098131-12
|
$2,161,998
|
$540,500
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
5R01CA154738-04
|
$550,634
|
$550,634
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
1R01CA182633-01
|
$704,800
|
$704,800
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Quantitative analysis of epithelial cell scatter
|
5R01CA138899-05
|
$312,983
|
$312,983
|
ASTHAGIRI, ANAND
|
NORTHEASTERN UNIVERSITY
|
|
Total relevant funding to Metastasis for this search: $362,567,754
|
